Medical and surgical treatment for secondary and tertiary hyperparathyroidism.
Prevention and treatment of secondary hyperparathyroidism (SHPT) in patients on chronic maintenance hemodialysis and of tertiary hyperparathyroidism (THPT) in patients after kidney transplantation is a challenge for the nephrologist and for the surgeon. Indication and results of medical and surgical therapy for SHPT and THPT have remained under discussion during the last decades. This review resumes the current medical and surgical strategies for patients with SHPT and THPT.
Schlosser
K
K
Department of Visceral, Thoracic and Vascular Surgery, Philipps-University, Marburg, Germany. pluntke@mailer.uni-marburg.de
Zielke
A
A
Rothmund
M
M
D001842:Bone and Bones / Q000378:metabolism / Q000473:pathology; D002118:Calcium / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D004032:Diet; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D006996:Hypocalcemia / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications*; D016030:Kidney Transplantation; D010281:Parathyroid Hormone / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D016105:Parathyroidectomy / Q000379:methods; D010744:Phosphoric Monoester Hydrolases / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D011182:Postoperative Care; D011183:Postoperative Complications; D012008:Recurrence; D006435:Renal Dialysis / Q000009:adverse effects; D014807:Vitamin D / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use
D010281:Parathyroid Hormone; D014807:Vitamin D; D010744:Phosphoric Monoester Hydrolases; D002118:Calcium